Clinical Roundup Among cancer survivors, LGBTQ+ individuals report higher prevalence of chronic health conditions, disabilities, other limitations June 21, 2024Vol.50 No.25
Clinical Roundup ASTRO updates guideline on radiation therapy for HPV-related throat cancer June 21, 2024Vol.50 No.25
Clinical Roundup Columvi combination extends OS in transplant-ineligible R/R DLBCL in phase III trial June 21, 2024Vol.50 No.25
Clinical Roundup Elrexfio produces median OS of >2 two years in R/R MM in single-arm phase II study June 21, 2024Vol.50 No.25
Clinical Roundup Combination targeted treatment produces lasting remissions in resistant aggressive DLBCL in phase Ib/II study June 21, 2024Vol.50 No.25
Clinical Roundup Oncology drugs approved post-2020 more likely to include postmarketing approaches to collecting data in underrepresented populations June 21, 2024Vol.50 No.25
Clinical Roundup NLRC5 is an innate immune sensor that plays a crucial role in PANoptotic cell death June 21, 2024Vol.50 No.25
Clinical Roundup CAR NK cells with CD28 costimulation improved cell persistence, antitumor activity June 21, 2024Vol.50 No.25
Clinical Roundup Fewer than 20% of U.S. adults eligible for lung cancer screening comply with USPSTF guideline June 14, 2024Vol.50 No.24
